- Home
- BBAR vs PTGX Comparison
BBAR vs PTGX Comparison
Compare BBAR & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBAR
- PTGX
- Stock Information
- Founded
- BBAR 1886
- PTGX 2006
- Country
- BBAR Argentina
- PTGX United States
- Employees
- BBAR N/A
- PTGX N/A
- Industry
- BBAR Commercial Banks
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- BBAR Finance
- PTGX Health Care
- Exchange
- BBAR Nasdaq
- PTGX Nasdaq
- Market Cap
- BBAR 1.8B
- PTGX 3.7B
- IPO Year
- BBAR N/A
- PTGX 2016
- Fundamental
- Price
- BBAR $8.89
- PTGX $59.44
- Analyst Decision
- BBAR Buy
- PTGX Strong Buy
- Analyst Count
- BBAR 1
- PTGX 9
- Target Price
- BBAR $27.00
- PTGX $70.44
- AVG Volume (30 Days)
- BBAR 1.1M
- PTGX 925.0K
- Earning Date
- BBAR 08-20-2025
- PTGX 11-06-2025
- Dividend Yield
- BBAR 0.25%
- PTGX N/A
- EPS Growth
- BBAR N/A
- PTGX N/A
- EPS
- BBAR 0.38
- PTGX 0.80
- Revenue
- BBAR $1,945,235,030.00
- PTGX $209,180,000.00
- Revenue This Year
- BBAR N/A
- PTGX N/A
- Revenue Next Year
- BBAR $23.38
- PTGX $248.17
- P/E Ratio
- BBAR $7.86
- PTGX $73.55
- Revenue Growth
- BBAR N/A
- PTGX N/A
- 52 Week Low
- BBAR $8.68
- PTGX $33.31
- 52 Week High
- BBAR $25.01
- PTGX $61.89
- Technical
- Relative Strength Index (RSI)
- BBAR 23.09
- PTGX 55.45
- Support Level
- BBAR $8.68
- PTGX $57.90
- Resistance Level
- BBAR $9.25
- PTGX $60.40
- Average True Range (ATR)
- BBAR 0.61
- PTGX 2.53
- MACD
- BBAR -0.20
- PTGX -0.11
- Stochastic Oscillator
- BBAR 4.88
- PTGX 63.87
About BBAR Banco BBVA Argentina S.A. ADS
Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focuses on foreign trade, agricultural business, and digital products.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.